News
Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
July 14, 2010 9:43 am | by Bio-Medicine.Org | CommentsLONDON , July 14 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") is pleased to announce a one-year extension of its ongoing research and development collaboration with AstraZeneca. Under the terms of the agreement, which has progressed well since being signed in...
Sector Snap: SEC inquiry sacks home health stocks
July 14, 2010 8:45 am | by The Associated Press | CommentsShares of home health providers sank Wednesday as an investigation into the industry's Medicare reimbursement practices expanded.After the markets closed on Tuesday, LHC Group Inc. and Gentiva Health Services Inc. said they are being investigated by the Securities and Exchange Commission. LHC...
Half of swine flu deaths were in previously healthy people, research finds
July 14, 2010 6:48 am | by EurekAlert | Comments(University of Liverpool) Over half of UK swine flu hospital admissions and inpatient deaths occurred in people with no underlying health problems or obvious risk factors, research at the University of Liverpool has found.
Researcher targets gene regulators on link between arsenic, cancer
July 14, 2010 6:48 am | by EurekAlert | Comments(Michigan State University) To determine how arsenic increases the risk of lung cancer and to identify potential treatments, a Michigan State University researcher will use $1.7 million in federal funding during the next five years to examine why certain genes disrupt cells,...
Federal Register: Town Hall Discussion With the Director of the Center for Devices and Radiological Health and Other Senior Center Management
July 14, 2010 5:32 am | by U.S. Food & Drug Administration | CommentsThe purpose of this meeting is to present the CDRH Fiscal Year (FY) 2010 Priorities. In addition, FDA is interested in engaging in discussions about issues that are of importance to the medical device industry.
Coumadin 1 mg Tablet Blister Packs: Recall(2)
July 14, 2010 5:31 am | by U.S. Food & Drug Administration | CommentsSome tablets may not meet specification for isopropanol, which could affect therapeutic levels of the active ingredient.
Study shows universal surveillance for MRSA significantly decreased HAIs at PCMH
July 13, 2010 9:36 pm | by EurekAlert | Comments(Manning Selvage & Lee) Pitt County Memorial Hospital today announced results of a study demonstrating that universal surveillance for methicillin-resistant Staphylococcus aureus decreased health care-associated infections related to devices. Infection rates decreased 68 percent...
The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011
July 13, 2010 9:36 pm | by EurekAlert | Comments(Samuel Waxman Cancer Research Foundation) The Samuel Waxman Cancer Research Foundation has awarded 13 collaborative grants and 3 individual grants, totaling $1.54 million to some of the best scientific minds in differentiation therapy.
Diabetes Risk, on a Scale of 1 to 10
July 13, 2010 9:34 pm | by Massachusetts Institute of Technology | CommentsA new test is transforming the way some doctors diagnose and treat their patients.
Arava (leflunomide): Boxed Warning - Risk of Severe Liver Injury
July 13, 2010 9:31 pm | by U.S. Food & Drug Administration | CommentsWarning highlights the risk of severe liver injury and how this risk may be reduced.
SEC tells LHC Group to preserve Medicare documents
July 13, 2010 3:45 pm | by The Associated Press | CommentsHome care and hospice provider LHC Group Inc. said Tuesday the Securities and Exchange Commission ordered it to preserve all documents relating to its Medicare-reimbursement practices.The SEC indicated it plans to request the documents later, the company said. LHC said it intends to cooperate...
Meridian Bioscience says FDA clears bacterium test
July 13, 2010 12:45 pm | by The Associated Press | CommentsMeridian Bioscience Inc. said Tuesday that the Food and Drug Administration has given approval to market Meridian's test for Clostridium difficile. Meridian, a medical test developer and maker, said it takes less than an hour to run the assay for illumigene C. difficile, a bacterium that can...
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
July 13, 2010 10:36 am | by Bio-Medicine.Org | CommentsSAN DIEGO , July 13 /- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, announced that it has secured a $35 million debt facility led by Oxford Finance Corporation which also included Silicon Valley Bank. The facility consists of a $25 million term loan and a $10...
Hanger Orthopedic Group, Inc. Announces Second Quarter 2010 Earnings Release Conference Call
July 13, 2010 10:36 am | by Bio-Medicine.Org | CommentsBETHESDA, Md. , July 13 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced today that it plans to report its results of operations for the quarter ended June 30, 2010 , on Tuesday, July 27, 2010 . The Company plans to issue a press release announcing the results for the quarter ended...
Parkview Medical Center Selects MobileMD for Health Information Exchange Service
July 13, 2010 10:36 am | by Bio-Medicine.Org | CommentsPUEBLO, Colo. , July 13 /- Parkview Medical Center recently announced an agreement with MobileMD, Warminster, Pa. , to provide state-of-the-art health information exchange (HIE) services to its physician and medical community. Parkview Medical Center is a non-profit general acute...
